Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
giovedì, ottobre 22
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
SkinHealth Systems Inc
SKIN
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$11.03
-0.13
-1.16%
Ult. Agg.: Oct 20, 8:30 AM
$11.43
0.27
2.42%
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Privacy Manager
SkinHealth Systems Financials
SkinHealth Systems (SKIN) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Beauty Health Sees Q3 Sales $65.000M-$70.000M vs $69.220M Est
Beauty Health (NASDAQ:SKIN) sees Q3 sales of $65.000 million-$70.000 million vs $69.220 million analyst estimate.
Benzinga Newsdesk
PRO
Beauty Health Narrows FY2026 Sales Guidance from $280.000M-$295.000M to $280.000M-$290.000M vs $289.529M Est
Beauty Health (NASDAQ:SKIN) narrows FY2026 sales outlook from $280.000 million-$295.000 million to $280.000 million-$290.000 million vs $289.529 million estimate.
Benzinga Newsdesk
PRO
Beauty Health Q2 EPS $(0.02), Inline, Sales $72.100M Miss $74.294M Estimate
Beauty Health (NASDAQ:SKIN) reported quarterly losses of $(0.02) per share which met the analyst consensus estimate. This is a 166.67 percent decrease over earnings of $0.03 per share from the same period last year.
Benzinga Newsdesk
PRO
Beauty Health Sees Q2 Sales $72.000M-$77.000M vs $76.764M Est
Beauty Health (NASDAQ:SKIN) sees Q2 sales of $72.000 million-$77.000 million vs $76.764 million analyst estimate.
Benzinga Newsdesk
PRO
Beauty Health Lowers FY2026 Sales Guidance from $285.000M-$305.000M to $280.000M-$295.000M vs $297.498M Est
Beauty Health (NASDAQ:SKIN) lowers FY2026 sales outlook from $285.000 million-$305.000 million to $280.000 million-$295.000 million vs $297.498 million estimate.
Benzinga Newsdesk
PRO
Beauty Health Q1 EPS $(0.05) Beats $(0.07) Estimate, Sales $64.900M Miss $66.448M Estimate
Beauty Health (NASDAQ:SKIN) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.07) by 28.57 percent. This is a 37.5 percent increase over losses of $(0.08) per share from the
Benzinga Newsdesk
